REV-ERB agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-02-11. Numbers and descriptions here follow the published literature rather than marketing material.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, dark | Protect from repeated temperature changes. |
| Common analytical method | LC-MS or HPLC-UV | Reference standard required for comparison. |
| Common synonyms | SR9009; Stenabolic; REV-ERB agonist | Vendor naming may vary. |
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
At the same time, the need for such a system was becoming increasingly pressing. In 1932, Winston Churchill and his friend, confidant and scientific advisor Frederick Lindemann travelled by car in Europe, where they saw the rapid rebuilding of the German aircraft industry. It was in November of that year that Stanley Baldwin gave his famous speech, stating that "The bomber will always get through". In the early summer of 1934, the RAF carried out large-scale exercises with up to 350 aircraft. The forces were split, with bombers attempting to attack London, while fighters, guided by the Observer Corps, attempted to stop them. The results were dismal. In most cases, the vast majority of the bombers reached their target without ever seeing a fighter. To address the one-sided results, the RAF gave increasingly accurate information to the defenders, eventually telling the observers where and when the attacks would be taking place. Even then, 70 per cent of the bombers reached their targets unhindered. The numbers suggested any targets in the city would be destroyed. Squadron Leader P. R. Burchall summed up the results by noting that "a feeling of defencelessness and dismay, or at all events of uneasiness, has seized the public." In November, Churchill gave a speech on "The threat of Nazi Germany" in which he pointed out that the Royal Navy could not protect Britain from an enemy who attacked by air. Through the early 1930s, a debate raged within British military and political circles about strategic airpower.
== Career == Awadis and his older brother Brandon (known online as Brawadis) started a shared YouTube channel called "fathersonchaldean" and posted their first video on the same day, October 11, 2008. They uploaded at least three more videos by the end of 2009. Afterwards, the channel became inactive, but is still on YouTube. These videos depicted a stereotypical view of a Chaldean father's attitude towards his son. Awadis created his own YouTube channel on July 11, 2012 under the name FaZe Rug on which he started posting short clips of Call of Duty gameplay. He was invited to join the esports team FaZe Clan, which Awadis would eventually co-own, in January 2013. He uploaded his first prank video on December 7, 2014. He spent the next thirteen years as a member of FaZe Clan. While YouTube remained his primary focus, Awadis expanded into several other entertainment ventures. In November 2019, Awadis released a song called "Goin' Live". A few months later, he was the featured guest in season 17, episode 7 of MTV's Ridiculousness on June 24, 2020. Awadis co-founded 1UP Candy in 2023, a candy brand that specializes in freeze dried candy. On December 27, 2025, Awadis announced that he had left FaZe Clan through a post on X. Following his departure, he has continued to pursue independent content on the YouTube platform while retaining the name "FaZe Rug".
Many Ni(III) compounds are known. Ni(III) forms simple salts with fluoride or oxide ions. Ni(III) can be stabilized by σ-donor ligands such as thiols and organophosphines. Ni(III) occurs in nickel oxide hydroxide, which is used as the cathode in many rechargeable batteries, including nickel–cadmium, nickel–iron, nickel–hydrogen, and nickel–metal hydride, and used by certain manufacturers in Li-ion batteries. Ni(IV) remains a rare oxidation state and very few compounds are known. Ni(IV) occurs in the mixed oxide BaNiO3.
==== Daily Mirror false allegations ==== Alleged photographs of prisoner abuses by UK troops were published by the Daily Mirror within 48 hours of the breaking of the story of abuses by US troops in the Abu Ghraib prison in Iraq. General Sir Mike Jackson, Chief of the General Staff, said "if proven, the perpetrators are not fit to wear the Queen's uniform and they have besmirched the Army's good name and conduct". The authenticity of the photographs was called into question a day later. In particular, a number of specifics in the images, such as the type of rifles the soldiers in the pictures are carrying and the type of truck pictured did not match the equipment used by UK troops in Iraq. The Mirror responded to these criticisms of the photographs on May 3, 2004. On May 14, 2004, the Daily Mirror reported that the pictures it had published, allegedly showing UK troops abusing an Iraqi prisoner, were fake and that "the Daily Mirror has been the subject of a calculated and malicious hoax." The Daily Mirror editor, Piers Morgan, was sacked due to the controversy.
Sources: en.wikipedia.org
On October 12, 2016, LLNL released the results of computerized modeling of Mars's moon Phobos, finding that it has a connection with keeping the Earth safe from asteroids. In December, 2022 scientists at Lawrence Livermore National Laboratory announced, in a breakthrough for fusion power technology, that they have used the technique of inertial confinement fusion to achieve a net gain of energy. The National Ignition Facility (NIF) became the first fusion reactor to achieve breakeven on December 5, 2022, with an experiment producing 3.15 megajoules of energy from a 2.05 megajoule input of laser light for an energy gain of about 1.5.
It is drained with each use and can be replenished by drinking from rats, visiting blood banks, or drinking from humans by attacking or seducing them; the player can feed on enemies during combat. Drinking from innocents for too long can kill them, costing a character humanity points. Players are penalized for using certain vampiric abilities in front of witnesses; exposing their existence loses masquerade points, although additional masquerade points can be earned from quests and other actions. Violating the masquerade five times draws the ire of vampire hunters and loses the game. The player has humanity points, representing the vampire's humanity. Some actions cost humanity points; a low humanity score alters available dialogue options to become more aggressive and increases the chance of entering a frenzied state and embarking on a killing spree when the vampire's blood is low. A large amount of damage can also trigger this frenzy. Like masquerade points, losing all humanity points ends the game, with the vampire becoming a mindless beast. Some areas, known as Elysium, prevent the use of Disciplines or weapons. Players can recruit a ghoul, Heather, as a customizable servant who gives them blood, gifts, and money.
Genetic factors may be the most significant cause of autism. Early studies of twins had estimated heritability to be over 90%, meaning that genetics explains over 90% of whether a child will develop autism. This may be an overestimation, as later twin studies estimate the heritability at between 60 and 90%. Evidence so far still suggests a strong genetic component, with one of the largest and most recent studies estimating the heritability at 83%. Many of the non-autistic co-twins had learning or social disabilities. For adult siblings, the probability of having one or more features constitutive of the broader autism phenotype may be as high as 30%. In spite of the strong heritability, most cases of autism occur sporadically with no recent evidence of family history. It has been hypothesized that spontaneous de novo mutations in the sperm or egg contribute to the likelihood of developing autism. Additionally, mutations of the Fragile X Messenger Ribonucleoprotein 1 (FMR1) which cause fragile X syndrome, one of the most common causes of intellectual disability and autism, have been linked to the early cessation of reproductive functions of female carriers in the gene. This substantiates the notion that those with autism are more likely to be infertile, weakening the heritability of the disorder. Also, the likelihood of having a child develop autism generally increases with advancing parental age, and mutations in sperm gradually accumulate throughout a man's life.
==== Rodent research ==== A study on the fossil record of Asian rodents spanning the last 55 million years, providing evidence of impact of tectonic and climatic changes on ecomorphological diversity of Asian rodent assemblages throughouth their evolutionary history, is published by Peng & Hopkins (2026). Pfaff, Ruf & Le Maître (2026) determine the locomotory behavior of extinct members of Eusciurida on the basis of the study of middle and inner ear of extant and extinct rodents, interpreting early rodents and sciurids as fossorial, with adaptations to arboreal lifestyle evolving in later taxa. Review of research on systematics of fossil dormice from Mediterranean islands from the preceding years is published by Fox & Hennekam (2026). Wei et al. (2026) reconstruct the evolutionary history of marmots on the basis of paleontological and molecular data. Murchie et al. (2026) report evidence of preservation of ancient environmental DNA of diverse Quaternary organisms from eastern Beringia in the Pleistocene and Holocene ground squirrel coprolites from Yukon (Canada), including evidence of previously unrecognized genetic diversity of Arctic members of the genus Urocitellus. Li, Bi & Li (2026) present the first virtual endocasts of Paleogene ctenodactyloids Exmus mini and Bounomys ulantatalensis. The first fossil material of Hystrix subcristata from Taiwan is reported from the Pleistocene Chiting Formation by Halaçlar & Lin (2026). Buldrini et al. (2026) describe fossil material of Phugatherium sp.
From its founding until the early 1990s, the menu at Domino's Pizza was kept simple relative to other fast food restaurants, to ensure efficiency of delivery. Historically, Domino's menu consisted solely of one style of pizza crust in two sizes (12-inch and 16-inch), eleven toppings, and Coca-Cola as the only soft drink option. The first menu expansion occurred in 1989, with the debut of Domino's deep dish. Its introduction followed market research showing that 40% of pizza customers preferred thick crusts. The new product launch cost approximately $25 million, of which $15 million was spent on new sheet metal pans with perforated bottoms. Domino's started testing extra-large-size pizzas in early 1993, starting with the 30-slice, yard-long "The Dominator". Domino's tapped into a market trend toward bite-size foods with spicy "Buffalo Chicken Kickers", as an alternative to Buffalo wings, in August 2002. The breaded, baked, white-meat fillets, similar to chicken fingers, are packaged in a custom-designed box with two types of sauce to "heat up" and "cool down" the chicken.
Sources: en.wikipedia.org
In the initial stages of allergy, a type I hypersensitivity reaction against an allergen encountered for the first time and presented by a professional antigen-presenting cell causes a response in a type of immune cell called a TH2 lymphocyte, a subset of T cells that produce a cytokine called interleukin-4 (IL-4). These TH2 cells interact with other lymphocytes called B cells, whose role is the production of antibodies. Coupled with signals provided by IL-4, this interaction stimulates the B cell to begin production of a large amount of a particular type of antibody known as IgE. Secreted IgE circulates in the blood and binds to an IgE-specific receptor (a kind of Fc receptor called FcεRI) on the surface of other kinds of immune cells called mast cells and basophils, which are both involved in the acute inflammatory response. At this stage, the IgE-coated cells are sensitized to the allergen. If later exposure to the same allergen occurs, the allergen can bind to IgE molecules held on the surface of the mast cells or basophils. Cross-linking of the IgE and Fc receptors occurs when more than one IgE-receptor complex interacts with the same allergenic molecule and activates the sensitized cell. Activated mast cells and basophils undergo a process called degranulation, during which they release histamine and other inflammatory chemical mediators (cytokines, interleukins, leukotrienes, and prostaglandins) from their granules into the surrounding tissue causing several systemic effects, such as vasodilation, mucous secretion, nerve stimulation, and smooth muscle contraction.
APEKTx1 is a highly selective blocker of the voltage-gated potassium channel Kv1.1 with no effect on other tested potassium channels (Kv1.2, Kv1.3, Kv1.4, Kv1.5, Kv1.6, Shaker IR, Kv2.1, Kv3.1, Kv4.2 and Kv4.3). APEKTx1 selectively blocks Kv1.1 channels with an IC50 value of 0.9 nM, which makes it between a 700 to 3000 times more potent inhibitor than the two known sea anemone peptides targeted against Kv channels (kalicludines and SHTX II). APEKTx1 is thought to interact with Kv1.1 through the aliphatic residue alanine (A352), an acidic residue glutamate (E353), and an aromatic residue tyrosine (Y379), as a mutation in these sites causes a loss in affinity of the toxin for Kv1.1. These residues are located in the H5-loop between the S5 and S6 domains and are part of the channel’s pore. In addition, APEKTx1 acts as a potent trypsin inhibitor (Kd= 124 nM), probably a competitive one. However, trypsin inhibition is more potent (as it has a higher affinity) in BPTI, which can be explained by the presence of Phe13 and Pro19 in APEKTx1, causing an unfavorable interaction.
=== Beta counting === Libby's first detector was a Geiger counter of his own design. He converted the carbon in his sample to lamp black (soot) and coated the inner surface of a cylinder with it. This cylinder was inserted into the counter in such a way that the counting wire was inside the sample cylinder, in order that there should be no material between the sample and the wire. Any interposing material would have interfered with the detection of radioactivity, since the beta particles emitted by decaying 14C are so weak that half are stopped by a 0.01 mm thickness of aluminium. Libby's method was soon superseded by gas proportional counters, which were less affected by bomb carbon (the additional 14C created by nuclear weapons testing). These counters record bursts of ionization caused by the beta particles emitted by the decaying 14C atoms; the bursts are proportional to the energy of the particle, so other sources of ionization, such as background radiation, can be identified and ignored. The counters are surrounded by lead or steel shielding, to eliminate background radiation and to reduce the incidence of cosmic rays. In addition, anticoincidence detectors are used; these record events outside the counter and any event recorded simultaneously both inside and outside the counter is regarded as an extraneous event and ignored.
The 2014 Farm Bill legalized the sale of "non-viable hemp material" grown within states participating in the Hemp Pilot Program which defined hemp as cannabis containing less than 0.3% of THC. The 2018 Farm Bill removed the hemp plant and all "derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis," including CBD, from the Controlled Substances Act, making them legal to manufacture in the United States. The FDA retains regulatory authority over hemp-derived CBD, while the DEA is not involved in the regulation of legally-compliant hemp and hemp products. The 2018 Farm Bill requires that research and development of CBD for a therapeutic purpose would have to be conducted under notification and reporting to the FDA. On April 23, 2026, the Department of Justice issued an order to immediately reclassify medical cannabis as a Schedule III controlled substance when dispensed by a state-licensed cannabis dispensary. The DEA is in the process of conducting expedited public hearings to address the broader rescheduling of all cannabis from Schedule I to Schedule III, with the hearings scheduled to begin June 29, 2026.
Topography has been applied to different science fields. In neuroscience, the neuroimaging discipline uses techniques such as EEG topography for brain mapping. In ophthalmology, corneal topography is used as a technique for mapping the surface curvature of the cornea. In tissue engineering, atomic force microscopy is used to map nanotopography. In human anatomy, topography is superficial human anatomy. In mathematics the concept of topography is used to indicate the patterns or general organization of features on a map or as a term referring to the pattern in which variables (or their values) are distributed in a space.
Sources: en.wikipedia.org
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.
The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.
Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.